Biosciences Division

News

• New ORNL process brings nanoparticles into focus

  Scientists can study the biological impacts of engineered nanomaterials on cells within the body with greater resolution than ever because of a procedure developed by researchers at the Department of Energy's Oak Ridge National Laboratory.

• Audio Spot: New medicine therapeutics company is spinout from ORNL

  A Company, NellOne Therapeutics, has been formed through Battelle Ventures to research the potential for a new therapy that could help heart patients, according to Oak Ridge National Laboratory scientist Cymbeline Culiat.

Top Research Highlights of 1997

• Two-photon excitation work featured in spectroscopy journal
• Lead, Asbestos, and Radon Assessment Project for the U. S. Postal Servicel
• Nuclear Medicine Group's research on coronary restenosis
• Protein crystal annealing
• Monoclonal antibodies developed in Life Sciences laboratory
• New technology from ORNL Nuclear Medicine Program licensed to radiopharmaceutical manufacturer
• ORNL technology puts Knoxville company in remediation fast lane
• Large-scale analytical processing capabilities developed by the Genome Channel and Genome Annotation Consortium
• Agouti Gene Research
• Bacteria to Degrade Hazardous Waste/Chemical Agents Developed
• RfD for Chemical Warefare Agent Determined
• Breast Cancer Treatment Developed
• New Direct DNA Sequencing Method Developed
• Gene Involved in Multigenic Inheritance of Obesity Identified
• Licenses Signed for ORNL Nuclear Medicine Technology
• Mouse Gene Discovery Leads to Human Disease Gene
• New Technique for Mapping DNA Molecules Developed
• Radioimmunotherapy with 213Bi Targeted to Blood Vessels
• Role of Critical Histidine Residue of Human EGF Identified
• SERGen Probe Technology Developed

 

• Research Highlights of 1996